U.S. Loses Key Case on Rights to H.I.V.-Prevention Drugs

U.S. Loses Key Case on Rights to H.I.V.-Prevention Drugs

In an unusual court trial, a federal jury sided with the drug maker Gilead Sciences in a dispute over who came up with the idea of using a daily pill to prevent H.I.V.
Goldman Sachs to Pay $215 Million to Settle Gender Bias Suit

Goldman Sachs to Pay $215 Million to Settle Gender Bias Suit

The lawsuit accused the Wall Street bank of hindering women’s career advancement and paying them less than their male colleagues.